Christine Alewine
American oncologist and biologist
Christine Campo Alewine is an American oncologist and biologist researching immunotoxin therapeutics in pancreatic cancer. She is an investigator at the National Cancer Institute.
Education
Campo completed a B.A. in chemistry and Asian studies at Dartmouth College. In college, she interned under chemist Karen Wetterhahn focusing on the environmental effects of toxic metals. It was in this lab that Alewine was introduced to MD–PhD programs and became interested in becoming a physician-scientist. She completed a postbaccalaureate program at the National Cancer Institute's laboratory of pathology from 1998 to 1999. Campo earned a M.D. and Ph.D. from the University of Maryland School of Medicine. Her dissertation in 2006 was titled, PDZ protein regulation of Kir 2.3. She completed internal medicine residency in the Osler Medical Training Program at Johns Hopkins Hospital followed by clinical fellowship in medical oncology at the NCI.
Career and research
She joined the NCI's laboratory of molecular biology as an assistant clinical investigator through the support of the clinical investigator development program in 2014 and became a tenure-track investigator through the NIH Lasker Scholar program in 2016. Alewine researches the use of immunotoxin therapeutics in pancreatic cancer.
The public source identifies “Christine Alewine” as american oncologist and biologist. This brief keeps that definition visible, then builds a research path around Christine, Alewine and American.
Why this record matters
A short description can identify a subject without explaining its stakes. For “Christine Alewine”, the useful work is to connect “american oncologist and biologist” to the records capable of establishing context and consequence.
Vocabulary and entity names are the principal evidence signals here, because they determine the precision of every later search. The source revision retrieved here is dated Aug 9, 2026. The linked authority identifier is Q91062280. VIAF identifies the subject as 231149294457680522472. The Library of Congress control number is n2017183108. None of the 2 selected statements returned an explicit reference. The first chronological checks are 1998, 1999, 2006 and 2014.
A concise general-reference account can conceal disagreements about scope, terminology or the weight assigned to individual sources. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “Christine Alewine”, its source revision and the description used here.
- Expand the search: follow Christine Alewine primary sources, Christine Alewine archive and Christine research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Christine Alewine”?
- Which institution is responsible for the underlying evidence?
- What terminology or title could unlock a more precise catalogue search?
Search terms from this dossier
This entry incorporates text from “Christine Alewine” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.